The diagnostics of COVID-19 to detect SARS-CoV-2-Variant B.1.1.529 using swabs of different sites of the upper airways

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00029710

Enrollment

Registered

2022-08-04

Start date

2022-06-27

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U07.1

Interventions

Group 1: The goal is the determination of the influence of the regions of the airways swabed on the viral load in samples. Especially nasopharyngeal swabs (NP), oropharyngeal swabs (OP), combined OP

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - concenting persons of age - patients with a suspected SARS-CoV-2 infection - no prior complication while swabing of airways

Exclusion criteria

Exclusion criteria: - regular intake of blood thinning medications - Complications with prior nasal or oral swabs - Strong sense of discomfort while receiving a swab - Patient with a surgical history in or pertinent the areas of the swabs

Design outcomes

Primary

Measure	Time frame
Evaluation of the relativ viral load in samples of different sites of the airways using the cycle-threshold-value.	—

Secondary

Measure	Time frame
The evaluation of the influence of labratory instruments on the cycle-threshold-value.	—

Countries

Germany

Contacts

Public ContactFlorian Dahms

Klinikum Stuttgart

f.dahms@klinikum-stuttgart.de+4971127830344

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026